EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature

Tanguy Viaene iD, Evelyn Dhont iD, Floris Vanommeslaeghe, Sunny Eloot iD, Filip De Somer iD, Jonathan De Rudder, Veerle Mondelaers iD, Evelien Snauwaert iD

Hemodialysis International · 2024

DOI: 10.1111/hdi.13181 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hemodialysis International, 2024. Verfasst von Tanguy Viaene und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Hirudins, Recombinant Proteins, Renal Dialysis, Peptide Fragments. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unfractionated heparin is the most used anticoagulative agent for extracorporeal settings in children, including acute hemodialysis modalities. In certain situations, such as heparin‐induced thrombocytopenia, alternatives must be applied. The direct thrombin inhibitor bivalirudin has come forth as an attractive substitute. Bivalirudin is currently only approved for adult use in specific percutaneous coronary intervention settings. However, it has a growing off‐label popularity in different contexts for both adult and pediatric patients. Experience with bivalirudin in children is mainly limited to extracorporeal membrane oxygenation, ventricular assist devices and during cardiopulmonary bypass surgery. Literature about its use as anticoagulation strategy for pediatric hemodialysis is very scarce. Here, we present two pediatric cases where bivalirudin was used during acute hemodialysis, followed by a short summary of recent literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HirudinsRecombinant ProteinsRenal DialysisPeptide FragmentsAnticoagulantsHumansMaleFemaleChildAdolescentChild, PreschoolAntithrombins

Stichwörter der Autor:innen

anticoagulationbivalirudindirect thrombin inhibitorextracorporealhemodialysispediatric

Substanzen

HirudinsbivalirudinRecombinant ProteinsPeptide FragmentsAnticoagulantsAntithrombins

Autor:innen und Institutionen

  • Department of Pediatrics, Ghent University Hospital, Ghent, Belgium.
  • Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.
  • Department of Nephrology, Member of the European Reference Network for Rare Kidney Diseases (ERKNet), Ghent University Hospital, Ghent, Belgium.
  • Department of Human Structure and Repair, Ghent University Hospital, Ghent, Belgium.
  • Department of Pediatric Hematology & Oncology, Ghent University Hospital, Ghent, Belgium.
  • Department of Pediatric Nephrology, Member of the European Reference Network for Rare Kidney Diseases (ERKNet), Ghent University Hospital, Ghent, Belgium.

ORCID-Profile: Tanguy Viaene, Evelyn Dhont, Sunny Eloot, Filip De Somer, Veerle Mondelaers, Evelien Snauwaert

Zitieren

APA

Viaene, T., Dhont, E., Vanommeslaeghe, F., Eloot, S., De Somer, F., De Rudder, J., Mondelaers, V., & Snauwaert, E. (2024). Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature. Hemodialysis International. https://doi.org/10.1111/hdi.13181

Vancouver

Viaene T, Dhont E, Vanommeslaeghe F, Eloot S, De Somer F, De Rudder J, et al. Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature. Hemodialysis International. 2024. doi:10.1111/hdi.13181

BibTeX
@article{Viaene2024,
  author = {Viaene, Tanguy and Dhont, Evelyn and Vanommeslaeghe, Floris and Eloot, Sunny and De Somer, Filip and De Rudder, Jonathan and Mondelaers, Veerle and Snauwaert, Evelien},
  title = {Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature},
  journal = {Hemodialysis International},
  year = {2024},
  doi = {10.1111/hdi.13181}
}
Kostenlos starten →